Biologics
UTime Signs NDA for Strategic Acquisition of Bowen Therapeutics Lab to Boost Global Vaccine Development
UTime Limited has officially announced the signing of a non-disclosure agreement (the "NDA") with Bowen Therapeutics Inc ("Bowen Therapeutics") for th...
August 29, 2024 | News
LOTTE Holdings Launches New CVC to Propel Innovations in Biopharmaceuticals and Next-Generation Modalities
LOTTE Holdings Co., Ltd. ("LOTTE Holdings") is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital ("...
August 29, 2024 | News
Mabwell Receives NMPA Approval to Initiate Phase III Study of 9MW2821 in Recurrent or Metastatic Cervical Cancer
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (C...
August 26, 2024 | News
CanariaBio Completes Enrollment for Phase 2 Study of Oregovomab with Chemotherapy in Advanced Ovarian Cancer
CanariaBio Inc, a leading late-stage biotechnology company, announces the successful completion of enrollment of 88 patients in a randomized Phase 2 study ...
August 26, 2024 | News
Yipurun's Corina System Receives Approval in China for Treating Moderate-to-Severe Intrauterine Adhesions
Corina Intrauterine Drug-Eluting System ("Corina"), developed by Yipurun (Shanghai) Biotechnology Co., Ltd. ("YPR"), has received approval i...
August 26, 2024 | News
Allozymes Partners with Adisseo to Transform Animal Feed Production with Innovative Bioprocesses
Allozymes, a leading innovator in enzyme discovery and engineering, announces a strategic partnership with Adisseo, one of the world's leading animal nutri...
August 20, 2024 | News
CARsgen Therapeutics Completes Enrollment in Pivotal Phase II Trial of Satri-Cel for Advanced Gastric Cancer in China
CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...
August 20, 2024 | News
Astellas Pharma Gains NMPA Approval for PADCEV™ in China to Treat Advanced Urothelial Cancer
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that the Center for Drug Evaluation (CDE) of C...
August 20, 2024 | News
Driving Healthcare Innovation in Asia: Rehan Saghir of ZP Therapeutics on Pioneering Drug Commercialization and Overcoming Regional Challenges
In an exclusive interview with BioPharma APAC, Rehan Saghir, Executive Vice President of ZP Therapeutics, Zuellig Pharma shares his expert insights...
August 20, 2024 | News
Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development
Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...
August 19, 2024 | News
Sanyou Biopharmaceuticals Launches Cutting-Edge "oneClick+" Platform for Intelligent Antibody Design
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. officially announced the launch of the "Sanyou Innovative Intelligent Antibody Design oneClick+ Platform." ...
August 16, 2024 | News
Nanoform and Takeda Collaborate on Pre-Clinical Development of Innovative Plasma-Derived Therapies
Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, announced that it is to enter into a pre-clinical development agreemen...
August 16, 2024 | News
Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC
Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...
August 15, 2024 | News
Mabwell's Nectin-4 Targeting ADC Receives Breakthrough Therapy Designation in China for Urothelial Carcinoma
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821)...
August 13, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
